Provided by Tiger Trade Technology Pte. Ltd.

ADC Therapeutics SA

4.60
+0.36008.49%
Post-market: 4.900.3000+6.52%18:19 EST
Volume:1.31M
Turnover:5.86M
Market Cap:569.83M
PE:-3.19
High:4.62
Open:4.30
Low:4.23
Close:4.24
52wk High:4.80
52wk Low:1.05
Shares:123.88M
Float Shares:92.24M
Volume Ratio:2.42
T/O Rate:1.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4417
EPS(LYR):-1.6246
ROE:-705.53%
ROA:-23.98%
PB:-2.39
PE(LYR):-2.83

Loading ...

ADC Therapeutics SA Publishes Corporate Presentation Highlighting ZYNLONTA® Expansion and Advancements in ADC Pipeline

Reuters
·
Oct 13

ADC Therapeutics Announces $60 Million Private Placement Led by TCGX and Redmile Group

Reuters
·
Oct 13

RBC Capital Keeps Their Buy Rating on ADC Therapeutics (ADCT)

TIPRANKS
·
Oct 10

Guggenheim Sticks to Their Buy Rating for ADC Therapeutics (ADCT)

TIPRANKS
·
Oct 08

ADC Therapeutics Grants Stock Options to New Employees Under Inducement Plan to Drive Company Growth

Reuters
·
Oct 02

ADC Therapeutics SA Unveils Corporate Presentation Highlighting ZYNLONTA Expansion and Progress on Next-Generation PSMA-Targeting ADC

Reuters
·
Sep 30

ADC Therapeutics SA Announces New Employee Inducement Plan with Option Grants to Motivate and Reward Performance

Reuters
·
Sep 03

ADC Therapeutics SA to Present at Cantor Global Healthcare Conference 2025

Reuters
·
Aug 27

ADC Therapeutics SA Reports Increased Net Loss of $56.6 Million in Q2 2025, EPS Down to $0.50; Product Revenues Rise to $18.1 Million

Reuters
·
Aug 12

BRIEF-ADC Therapeutics Q2 Income From Operations USD -44.147 Million Vs. IBES Estimate USD -44.5 Million

Reuters
·
Aug 12

ADC Therapeutics - Q2 Adj Loss per Share $0.25

THOMSON REUTERS
·
Aug 12

ADC Therapeutics Q2 Revenue USD 18.839 Million VS. Ibes Estimate USD 17.9 Million

THOMSON REUTERS
·
Aug 12

ADC Therapeutics Q2 Net Income USD -56.646 Million VS. Ibes Estimate USD -53.3 Million

THOMSON REUTERS
·
Aug 12

ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

THOMSON REUTERS
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

ADC Therapeutics SA to Release Second Quarter 2025 Financial Results

Reuters
·
Aug 06

ADC Therapeutics SA Announces New Inducement Plan with Stock Option Grants to Attract Top Talent

Reuters
·
Aug 02

ADC Therapeutics SA expected to post a loss of 47 cents a share - Earnings Preview

Reuters
·
Aug 01

ADC Therapeutics Announces New Inducement Plan Granting Stock Options to New Employee

Reuters
·
Jul 02

ADC Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones
·
Jun 20